Consensus Conference on the DGVS on Gastroesophageal reflux. Subject group II: Diagnosis;Gastroösophageale Refluxkrankheit - Ergebnisse einer evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankhelten: Themenkomplex II: Diagnostik

Zeitschrift fur Gastroenterologie

Volumn 43, Issue 2, 2005, Pages 168-175

  Muller Lissner S ^a   Fibbe, C ^a   Frieling, T ^a   Jung, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

BIOPSY; CONFERENCE PAPER; CONSENSUS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DUODENOGASTRIC REFLUX; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; HUMAN; MANOMETRY; PH MEASUREMENT; RADIOGRAPHY; SYMPTOMATOLOGY; BILE REFLUX; CLASSIFICATION; CONSENSUS DEVELOPMENT; DIFFERENTIAL DIAGNOSIS; ESOPHAGUS; GASTROSCOPY; HEARTBURN; MUCOSA; PATHOLOGY; PREDICTION AND FORECASTING; REFLUX ESOPHAGITIS; STOMACH PH;

BILE REFLUX; BIOPSY; DIAGNOSIS, DIFFERENTIAL; ESOPHAGITIS, PEPTIC; ESOPHAGUS; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HEARTBURN; HUMANS; MANOMETRY; MUCOUS MEMBRANE; PREDICTIVE VALUE OF TESTS;

EID: 22944490892     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-857872     Document Type: Conference Paper

References (101)

1. Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastrooesophageal reflux disease. Lancet 1990; 335: 205-208
2. Schindlbeck NE, Klauser AG, Berghammer G et al. Three year follow-up of patients with gastro-oesophageal reflux disease. Gut 1992; 33: 1016-1019
3. Martinez-Serna T, Tercero FJ, Filipi CJ et al. Symptom priority ranking in the care of gastroesophageal reflux: a review of 1,850 cases. Dig Dis 1999; 17: 219-224
4. Berstad A, Hatlebakk JG. The predictive value of symptoms in gastrooesophageal reflux disease. Scand J Gastroenterol Suppl 1995; 211: 1-4
5. Johnsson F, Joelsson B, Gudmundsson K et al. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1987; 22: 714-718
6. Garcia-Compean D, Gonzalez MV et al. Prevalence of gastroesophageal reflux disease with extraesophageal symptoms referred from otolaryngology, allergy, and cardiology practices: a prospective study. Dig Dis 2000; 18: 178-182
7. Guedon C. How to diagnose gastroesophageal reflux? Part 1 Diagnostic value of symptoms. Interpretation and role of endoscopy. Gastroenterol Clin Biol 1999; 23: S202-S207
8. Muller-Lissner. Diagnostic value of symptoms in gastroesophageal reflux disease. Gastroenterol Clin Biol 1999; 23: S13-S16
9. Gudmundsson K, Johnsson F, Joelsson B. The time pattern of gastroesophageal reflux. Scand J Gastroenterol 1988; 23: 75-79
10. Robertson DA, Aldersley MA et al. Patterns of acid reflux in complicated oesophagitis. Gut 1987; 28: 1484-1488
11. Galmiche JP, Barthelemy P et al. Treating the symptoms of gastrooesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997; 11: 765-773
12. Lind T, Havelund T et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997; 32: 974-979
13. Smout AJPM. Endoscopic-negative acid reflux disease. Aliment Pharmacol Ther 1997; 11 (suppl): 81-85
14. Dent J, Brun J, Fendrick A et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999; 44: S1-S16
15. Hotz J, Madisch A, Classen M et al. Internationaler Konsens zur Reflux-krankheit der Speiseröhre. Dtsch Med Wschr 2000; 125: 1308-1312
16. Schindlbeck NE, Wiebecke B, Klauser AG et al. Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease. Gut 1996; 39: 151-154
17. Ollyo JB, Gontollier C, Brossard E et al. La nouvelle classification de Savary des oesophagites de reflux. Acta Endoscopica 1992; 22: 307
18. Armstrong D. Endoscopic evaluation of gastro-esophageal reflux disease. Yale J biol Med 1999; 72: 93-100
19. Jones MP, Sloan SS, Rabine JC et al. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol 2001; 96 (6): 1711-1717
20. Öberg S, Peters JH, DeMeester TR et al. Endoscopic grading of the gastroesophageal valve in patients with symptoms of gastroesophageal reflux disease (GERD). Surg Endosc 1999; 13: 1184-1188
21. Achem SR. Endoscopy-negative gastroesophageal reflux disease. The hypersensitive esophagus. Gastroenterol Clin North America 1999; 28: 893-904
22. Galmiche JP, des Varannes SB. Endoscopy-negative reflux disease. Curr Gastroenterol Rep 2001; 3: 206-214
23. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-180
24. Vieth M, Stolte M. Can an endoscopically negative reflux disease be histologically diagnosed? Z Gastroenterol 2000; 38: 817-818
25. Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970; 58: 163-174
26. Seefeld U, Krejs GJ, Siebenmann RE et al. Esophageal histology in gastroesophageal reflux: Morphometric findings in suction biopsies. Dig Dis Sci 1977; 22: 956-964
27. Collins JSA, Watt PCH, Hamilton PW et al. Assessment of oesophagitis by histology and morphometry. Histopathology 1989; 14: 381-389
28. Morrow JB, Vargow JJ, Goldblum JR et al. The Ringed Esophagus: Histological Features of GERD. Am J Gastroenterol 2001; 96: 984-989
29. Bytzer P, Moller Hansen J, de Schaffalitzky Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994; 343: 811-816
30. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996; 110: 72-83
31. Fass R, Fennerty MB, Ofman JJ et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998; 115: 42-49
32. Jaup BH. Effective acid inhibition as a diagnostic tool for gastroesopheagel reflux disease. Gut 1995; 37 (Suppl 2): A36
33. Johnsson F, Weyvadt L, Solhaug JH et al. One week omeprazole treatment as a diagnostic test for gastro-oesophageal reflux disease. Gut 1996; 39 (Suppl 1): A39
34. Numans ME, Lau J, de Wit NJ et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004; 140: 518-527
35. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC et al. Omeprazole as a diagnsotiv tool in gastroesophageal reflux disease. Am J Gastroenterol 1997; 92: 1997-2000
36. Schindlbeck NE, Klauser AG, Voderholzer WA et al. Empiric therapy for gastroesophageal reflux disease. Arch Intern Med 1995; 155: 1808-12
37. Zierer MD, Sanowski RA, Young MF et al. Can a single dose of omeprazole be used to identify gastroesophageal reflux and acid-related chest pain? Am J Gastroenterology 1993; 88: 1501
38. Fass R, Ofman JJ, Sampliner RE et al. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther 2000; 14: 389-396
39. Leite LP, Johnston BT, Just RJ et al. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstating failure of omeprazole therapy. Am J Gastroenterol 1996; 91 (8): 1527-1531
40. Maton PN, Orlando R, Joelsson B. Efficacy of omepiazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease - a prospective controlled trial. Aliment Pharmacol Ther 1999; 13: 819-826
41. Richter JE, Kahrilas PJ, Johanson J et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol 2001; 96: 656-665
42. Festen HPM, Schenk E, Tan G et al. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. Am J Gastroenterol 1999; 94: 931-936
43. Watson RGP, Tham TCK, Johnston BT et al. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux - the "sensitive oesophagus". Gut 1997; 40: 587-590
44. Ergun GA, Kahrilas PJ. Clinical applications of esophageal manometry and pH monitoring. Am J Gastroenterol 1996; 91: 1077-1089
45. Locke GR, Talley NJ. 24-hour monitoring for gastro-oesophageal reflux disease. Lancet 1993; 342: 1246-1247
46. Richter JE. Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management. Gastroenterol Clin North Am 1996; 25: 75-102
47. Fuchs KH, DeMeester TR, Albertucci M. Specificity and sensitivity of objective diagnosis of gastroesophageal reflux disease. Surgery 1987; 102: 575-580
48. Waring JP, Hunter JG, Oddsdottir M et al. The preoperative evaluation of patients considered for laparoscopic antireflux surgery. Am J Gastroenterol 1995; 90: 35-38
49. Ghillebert G, Demeyere AM, Janssens J et al. How well can quantitative 24-hour intraesophageal pH monitoring distinguish various degrees of reflux disease? Dig Dis Sci 1995; 40: 1317-1324
50. Ask P, Edwall G, Johansson KE. Accuracy and choice of procedures in 24-hour oesophageal pH monitoring with monocrystalline antimony electrodes. Med Biol Eng Comput 1986; 24: 602-608
51. Richter JE, Bradley LA, DeMeester TR et al. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992; 37: 849-856
52. Vandenplas Y, Helven R, Goyvaerts H. Comparative study of glass and antimony electrodes for continuous oesophageal pH monitoring. Gut 1991; 32: 708-712
53. Dobhan R, Castell DO. Normal and abnormal esophageal acid exposure: results of ambulatory dual-probe monitoring. Am J Gastroenterol 1993; 88: 25-29
54. Wo JM, Hunter JG et al. Dual-channel ambulatory esophageal pH monitoring. A useful diagnostic tool? Dig Dis Sci 1997; 42: 2222-2226
55. Johnson LF, DeMeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974; 62: 325-332
56. DeVault KR, Castell DO. A simplified technique for accurate placement of ambulatory pH probes. Am J Gastroenterol 1991; 86: 380-381
57. Kahrilas PJ, Quigley EM. Clinical esophageal pH recording a technical review for pratice guideline development. Gastroenterology 1996; 110: 1982-1996
58. Dhiman RK, Saraswat VA, Mishra A et al. Inclusion of supine period in short-duration pH monitoring is essential in diagnosis of gastroesophageal reflux disease. Dig Dis Sci 1996; 41: 764-772
59. Dinelli M, Passaretti S, Di FI et al. Area under pH 4: a more sensitive parameter for the quantitative analysis of esophageal acid exposure in adults. Am J Gastroenterol 1999; 94: 3139-3144
60. Schindlbeck NE, Heinrich C, Konig A et al. Optimal thresholds, sensitivity and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology 1987; 93: 85-90
61. Schindlbeck NE, Ippisch H, Klauser AG et al. Which pH threshold is best in esophageal pH monitoring? Am J Gastroenterol 1991; 86: 1138-1141
62. Breumelhof R, Smout AJ. The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 1991; 86: 160-164
63. Johnston BT, McDougall N, Collins JS et al. Association of symptoms with acid reflux during esophageal pH monitoring. Dig Dis Sci 1994; 39: 1593-1594
64. Weusten BL, Roelofs JM, Akkermans LM et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107: 1741-1745
65. Wiener GJ, Richter JE, Copper JB et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988; 83: 358-361
66. Eckardt VF, Dilling B, Bernhard G. The impact of open access 24-h pH-metry on the diagnosis and management of esophageal reflux disease. Am J Gastroenterol 1999; 94: 616-621
67. Kahrilas PJ, Clouse RE, Hogan WJ. American Gastroenterological Association. Technical Review on the clinical use of esophageal manometry. Gastroenterology 1994; 107: 1865-1884
68. www.neurogastro.de
69. Fang J, Bjorkman D. Prefundoplication testing: is manometry needed? Am J Gastroenterol 2002; 97 (4): 1056-1058 (no abstract available)
70. Fibbe C, Layer P, Keller J et al. Esophageal motility in reflux disease before and after laparoscopic fundoplication. A prospective, randomized clinical and manometric study disease. Gastroenterology 2001; 121: 5-14
71. Gill RC, Bowes KL, Murphy PD et al. Esophageal motor abnormalities in gastroesophageal reflux and the effects of Fundoplication. Gastroenterology 1986; 91: 364-369
72. Gadenstatter M, Klingler A, Prommegger R et al. Laparoscopic partial posterior fundoplication provides excellent intermediate results in GERD patients with impaired esophageal peristalsis. Surgery 1999; 126: 548-552
73. Gadenstatter M, Klingler A, Klocker H et al. Long-term results of laparoscopic partial posterior fundoplication in patients with esophageal reflux and disorders of esophageal peristalsis. Wien Klin Wochenschr 2000; 112: 70-74
74. Lund RJ, Welcher GJ, Raiser F et al. Laparoscopic Toupet Fundoplication for Gastroesophageal Reflux Disease With Poor Esophageal Body Motility. J Gastrointest Surg 1997; 1: 301-308
75. Wetscher GJ, Glaser K, Gadenstaetter M et al. The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture. Am J Surg 1999; 177: 189-192
76. Johnston BT, Troshinsky MB, Castell JA et al. Comparison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophageal reflux disease. Am J Gastroenterol 1996; 91: 1181-1185
77. Ott DJ, Glauser SJ, Ledbetter MS et al. Association of hiatal hernia and gastroesophageal reflux: correlation between presence and size of hiatal hernia and 24-hour pH monitoring of the esophagus. AJR Am J Roentgenol 1995; 165: 557-559
78. Ferguson MK. Pitfalls and complications of anti reflux surgery. Nissen and Collis-Nissen techniques. Chest Surg Clin N Am 1997; 7: 489-509
79. Marshall RE, Anggiansah A, Manifold DK et al. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barren's oesophagus. Gut 1998; 43: 603-606
80. Vaezi MF, Richter JE, Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 1995; 117: 699-704
81. Vaezi MF, Richter JE. Duodenogastro-oesophageal reflux. Baillieres Best Pract Res Clin Gastroenterol 2000; 14: 719-729
82. Barrett MW, Myers JC, Watson DI et al. Detection of bile reflux: in vivo validation of the Bilitec fibreoptic system. Dis Esophagus 2000; 13: 44-50
83. Caldwell MT, Lawlor P, Byrne PJ et al. Ambulatory oesophageal bile reflux monitoring in Barren's oesophagus. Br J Surg 1995; 82; 657-660
84. Champion G, Richter JE, Vaezi MF et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 1994; 107: 747-754
85. Kauer WK, Peters JH, DeMeester TR et al. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995; 222: 525-531
86. Vaezi MF, Lacamera RG, Richter JE. Validation studies of Bilitec 2000: an ambulatory duodenogastric reflux monitoring system. Am J Physiol 1994; 267: G1050-1057
87. Cuomo R, Koek G, Sifrim D et al. Analysis of ambulatory duodenogastroesophageal reflux monitoring. Dig Dis Sci 2000; 45: 2463-2469
88. Marshall RE, Anggiansah A, Owen WA et al. The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease. Gut 1997; 40: 182-187
89. Marshall RE, Anggiansah A, Owen WA et al. The temporal relationship between oesophageal bile reflux and pH in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 1998; 10: 385-392
90. Menges M, Muller M, Zeitz M. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol 2001; 96: 331-337
91. Nehra D, Howell P, Williams CP et al. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 1999; 44: 598-602
92. Vaezi MF, Richter JE. Bile reflux in columnar-lined esophagus. Gastroenterol Clin North Am 1997; 26: 565-582
93. Dreuw B, Fass J, Buchin P et al. Combined pH measurement and multiple impedance variation assessments - validation of a new technique for detection of non-acid reflux in the esophagus. Langenbecks Arch Chir Suppl Kongressbd 1998; 115: 1143-1145
94. Frieling T, Hermann S, Kuhlbusch R et al. Comparison between intraluminal multiple electric impedance measurement and manometry in the human oesophagus. Neurogastroenterol Motil 1996; 8: 45-50
95. Nguyen HN, Silny J, Albers D et al. Dynamics of esophageal bolus transport in healthy subjects studied using multiple intraluminal impedancometry. Am J Physiol 1997; 273: G958-964
96. Sifrim D, Holloway R, Silny J et al. Composition of the postprandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 647-655
97. Sifrim D, Silny J, Holloway RH et al. Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: a study using intraluminal electrical impedance. Gut 1999; 44: 47-54
98. Srinivasan R, Vela MF, Katz PO et al. Esophageal function testing using multichannel intraluminal impedance. Am J Physiol Gastrointest Liver Physiol 2001; 280: G457-462
99. Katz PO. Review article: the role of non-acid reflux in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000; 14: 1539-1551
100. Nguyen HN, Silny J, Matern S. Multiple intraluminal electrical impedancometry for recording of upper gastrointestinal motility: current results and further implications. Am J Gastroenterol 1999; 94: 306-317
101. Tack J, Sifrim D, New techniques for the detection of gastro-oesophageal reflux. Dig Liver Dis 2000; 32 (Suppl 3): S245-248